Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function

Meikle L, Kwiatkowski DJ et al. · 2008 · The Journal of neuroscience · Atlas ID MEI2008

What this study shows

mTOR inhibition rescues a neuronal tuberous-sclerosis model, supporting rapamycin for TSC neurology.

Abstract

ShowHide

Tuberous sclerosis (TSC) is a hamartoma syndrome attributable to mutations in either TSC1 or TSC2 in which brain involvement causes epilepsy, mental retardation, and autism. We have reported recently a mouse neuronal model of TSC in which Tsc1 is ablated in most neurons during cortical development. We have tested rapamycin and RAD001, both mammalian target of rapamycin mTORC1 inhibitors, as potential therapeutic agents in this model. Median survival is improved from 33 d to more than 100 d; behavior, phenotype, and weight gain are all also markedly improved.

Read the full abstract on PubMed →

At a glance

Evidence type A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse (Tsc1 neuronal KO)); the code names the system studied -- animal work can be rigorous and still not be human data.
Study type4 - Animal Study
Model systemMouse (Tsc1 neuronal KO)
JournalThe Journal of neuroscience
Year2008
Peer reviewedYes
Record last updated2026-08-22
SourceDOI 10.1523/JNEUROSCI.0955-08.2008 · PMID 18495876 · Free full text (PMC2633923)

Extracted findings

InterventionRapamycin / RAD001 (mTORC1 inhibition)
TargetmTORC1 / Akt
ModelMouse (Tsc1 neuronal KO)
EffectmTOR inhibitors improve survival and function in a neuronal model of tuberous sclerosis

Cite this paper

ShowHide
Meikle, L., et al. (2008). Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. The Journal of neuroscience. https://doi.org/10.1523/JNEUROSCI.0955-08.2008

@article{MEI2008,
  author       = {Meikle, L. and Kwiatkowski, D. J. and others},
  title        = {{Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function}},
  journal      = {The Journal of neuroscience},
  year         = {2008},
  doi          = {10.1523/JNEUROSCI.0955-08.2008},
  note         = {PMID: 18495876},
}

Cite this Atlas record

The record is the Atlas's own work — the evidence label, the extracted findings and the links. It is cited as part of the dataset, not as the paper.

Barton, O. (2026). Oliver's mTOR Atlas (record MEI2008) [Data set]. https://mtor-atlas.org/study/MEI2008/ · Dataset DOI 10.5281/zenodo.22059963

@misc{atlas_MEI2008,
  author       = {Barton, Oliver},
  title        = {{Oliver's mTOR Atlas}, record MEI2008},
  howpublished = {Data set},
  year         = {2026},
  url          = {https://mtor-atlas.org/study/MEI2008/},
  doi          = {10.5281/zenodo.22059963}
}